Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly D Flemming

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
Neurology|December 21, 2018
Cerebral microbleeds: Prevalence and relationship to amyloid burdenJonathan Graff-Radford, Hugo Botha, Alejandro A Rabinstein, et al.
The Lancet. Neurology|December 15, 2015
Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient dataMargaret A Horne, Kelly D Flemming, I-Chang Su, et al.
Neurosurgery|May 21, 2025
Guidelines for the Diagnosis and Clinical Management of Cavernous Malformations of the Brain and Spinal Cord: Consensus Recommendations Based on a Systematic Literature Review by the Alliance to Cure Cavernous Malformation Clinical Advisory Board Experts PanelAmy L Akers, John Albanese, Roberto J Alcazar-Felix, et al.
Neurosurgery|November 27, 2018
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) TrialSean P Polster, Agnieszka Stadnik, Amy L Akers, et al.
Neurology|November 10, 2017
Brain microbleeds, anticoagulation, and hemorrhage risk: Meta-analysis in stroke patients with AFAndreas Charidimou, Christopher Karayiannis, Tae-Jin Song, et al.
Stroke|September 16, 2021
Baseline Characteristics of Patients With Cavernous Angiomas With Symptomatic Hemorrhage in Multisite Trial Readiness ProjectHelen Kim, Kelly D Flemming, Jeffrey A Nelson, et al.
Stroke|December 22, 2023
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part I: Event Rates and Clinical OutcomeKelly D Flemming, Helen Kim, Stephanie Hage, et al.
Stroke|December 22, 2023
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial ModelingStephanie Hage, Serena Kinkade, Romuald Girard, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Cavernous Angioma Symptomatic Hemorrhage (CASH) Trial Readiness II: Imaging Biomarkers and Trial ModelingStephanie Hage, Serena Kinkade, Romuald Girard, et al.
Neurology|July 10, 2025
Lifetime Risk of First Symptomatic ICH or Seizure in Familial Cerebral Cavernous Malformations: A Multicenter Patient Data AnalysisPhilipp Dammann, Alejandro N Santos, Laven Mavarani, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Neurology|December 21, 2018
Cerebral microbleeds: Prevalence and relationship to amyloid burdenJonathan Graff-Radford, Hugo Botha, Alejandro A Rabinstein, et al.
The Lancet. Neurology|December 15, 2015
Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient dataMargaret A Horne, Kelly D Flemming, I-Chang Su, et al.
Neurosurgery|May 21, 2025
Guidelines for the Diagnosis and Clinical Management of Cavernous Malformations of the Brain and Spinal Cord: Consensus Recommendations Based on a Systematic Literature Review by the Alliance to Cure Cavernous Malformation Clinical Advisory Board Experts PanelAmy L Akers, John Albanese, Roberto J Alcazar-Felix, et al.
Neurosurgery|November 27, 2018
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) TrialSean P Polster, Agnieszka Stadnik, Amy L Akers, et al.
Neurology|November 10, 2017
Brain microbleeds, anticoagulation, and hemorrhage risk: Meta-analysis in stroke patients with AFAndreas Charidimou, Christopher Karayiannis, Tae-Jin Song, et al.
Stroke|September 16, 2021
Baseline Characteristics of Patients With Cavernous Angiomas With Symptomatic Hemorrhage in Multisite Trial Readiness ProjectHelen Kim, Kelly D Flemming, Jeffrey A Nelson, et al.
Stroke|December 22, 2023
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part I: Event Rates and Clinical OutcomeKelly D Flemming, Helen Kim, Stephanie Hage, et al.
Stroke|December 22, 2023
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial ModelingStephanie Hage, Serena Kinkade, Romuald Girard, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Cavernous Angioma Symptomatic Hemorrhage (CASH) Trial Readiness II: Imaging Biomarkers and Trial ModelingStephanie Hage, Serena Kinkade, Romuald Girard, et al.
Neurology|July 10, 2025
Lifetime Risk of First Symptomatic ICH or Seizure in Familial Cerebral Cavernous Malformations: A Multicenter Patient Data AnalysisPhilipp Dammann, Alejandro N Santos, Laven Mavarani, et al.
Pageof 13